Utility  ||| S:0 E:8 ||| NN
of  ||| S:8 E:11 ||| IN
the  ||| S:11 E:15 ||| DT
ENEAS  ||| S:15 E:21 ||| NNP
study  ||| S:21 E:27 ||| NN
screening  ||| S:27 E:37 ||| NN
guide  ||| S:37 E:43 ||| NN
in  ||| S:43 E:46 ||| IN
a  ||| S:46 E:48 ||| DT
long-stay  ||| S:48 E:58 ||| JJ
chronic  ||| S:58 E:66 ||| JJ
care  ||| S:66 E:71 ||| NN
hospital  ||| S:71 E:80 ||| NN
Because  ||| S:80 E:88 ||| IN
of  ||| S:88 E:91 ||| IN
the  ||| S:91 E:95 ||| DT
characteristics  ||| S:95 E:111 ||| NN
of  ||| S:111 E:114 ||| IN
patients  ||| S:114 E:123 ||| NNS
with  ||| S:123 E:128 ||| IN
multimorbidities ||| S:128 E:144 ||| NN
,  ||| S:144 E:146 ||| ,
the  ||| S:146 E:150 ||| DT
methodology  ||| S:150 E:162 ||| NN
used  ||| S:162 E:167 ||| VBN
in  ||| S:167 E:170 ||| IN
acute  ||| S:170 E:176 ||| JJ
care  ||| S:176 E:181 ||| NN
hospitals  ||| S:181 E:191 ||| NNS
is  ||| S:191 E:194 ||| VBZ
unsuitable  ||| S:194 E:205 ||| VBN
to  ||| S:205 E:208 ||| TO
obtain  ||| S:208 E:215 ||| VB
valid  ||| S:215 E:221 ||| JJ
results  ||| S:221 E:229 ||| NNS
in  ||| S:229 E:232 ||| IN
long-stay  ||| S:232 E:242 ||| JJ
chronic  ||| S:242 E:250 ||| JJ
care  ||| S:250 E:255 ||| NN
hospitals ||| S:255 E:264 ||| NNS
.  ||| S:264 E:266 ||| .
The  ||| S:266 E:270 ||| DT
present  ||| S:270 E:278 ||| JJ
study  ||| S:278 E:284 ||| NN
aimed  ||| S:284 E:290 ||| VBN
to  ||| S:290 E:293 ||| TO
determine  ||| S:293 E:303 ||| VB
the  ||| S:303 E:307 ||| DT
utility  ||| S:307 E:315 ||| NN
of  ||| S:315 E:318 ||| IN
the  ||| S:318 E:322 ||| DT
screening  ||| S:322 E:332 ||| NN
guide  ||| S:332 E:338 ||| NN
used  ||| S:338 E:343 ||| VBN
in  ||| S:343 E:346 ||| IN
acute  ||| S:346 E:352 ||| JJ
care  ||| S:352 E:357 ||| NN
hospitals  ||| S:357 E:367 ||| NNS
to  ||| S:367 E:370 ||| TO
study  ||| S:370 E:376 ||| VB
adverse  ||| S:376 E:384 ||| JJ
events  ||| S:384 E:391 ||| NNS
( ||| S:391 E:392 ||| -LRB-
AE ||| S:392 E:394 ||| NNP
)  ||| S:394 E:396 ||| -RRB-
in  ||| S:396 E:399 ||| IN
long-stay ||| S:399 E:408 ||| NNP
,  ||| S:408 E:410 ||| ,
chronic  ||| S:410 E:418 ||| JJ
care  ||| S:418 E:423 ||| NN
hospitals  ||| S:423 E:433 ||| NNS
and  ||| S:433 E:437 ||| CC
to  ||| S:437 E:440 ||| TO
identify  ||| S:440 E:449 ||| VB
the  ||| S:449 E:453 ||| DT
factors  ||| S:453 E:461 ||| NNS
that  ||| S:461 E:466 ||| WDT
could  ||| S:466 E:472 ||| MD
improve  ||| S:472 E:480 ||| VB
the  ||| S:480 E:484 ||| DT
adjustment  ||| S:484 E:495 ||| NN
of  ||| S:495 E:498 ||| IN
this  ||| S:498 E:503 ||| DT
screening  ||| S:503 E:513 ||| NN
guide  ||| S:513 E:519 ||| NN
to  ||| S:519 E:522 ||| TO
these  ||| S:522 E:528 ||| DT
hospitals ||| S:528 E:537 ||| NNS
.  ||| S:537 E:539 ||| .
We  ||| S:539 E:542 ||| PRP
performed  ||| S:542 E:552 ||| VBD
a  ||| S:552 E:554 ||| DT
retrospective  ||| S:554 E:568 ||| JJ
cohort  ||| S:568 E:575 ||| JJ
study  ||| S:575 E:581 ||| NN
from  ||| S:581 E:586 ||| IN
January  ||| S:586 E:594 ||| NNP
1  ||| S:594 E:596 ||| CD
to  ||| S:596 E:599 ||| TO
December  ||| S:599 E:608 ||| NNP
31 ||| S:608 E:610 ||| CD
,  ||| S:610 E:612 ||| ,
2004  ||| S:612 E:617 ||| CD
and  ||| S:617 E:621 ||| CC
cross-sectional  ||| S:621 E:637 ||| JJ
studies  ||| S:637 E:645 ||| NNS
in  ||| S:645 E:648 ||| IN
2005 ||| S:648 E:652 ||| CD
,  ||| S:652 E:654 ||| ,
2006 ||| S:654 E:658 ||| CD
,  ||| S:658 E:660 ||| ,
2007  ||| S:660 E:665 ||| CD
and  ||| S:665 E:669 ||| CC
2008  ||| S:669 E:674 ||| CD
in  ||| S:674 E:677 ||| IN
a  ||| S:677 E:679 ||| DT
long-stay  ||| S:679 E:689 ||| JJ
chronic  ||| S:689 E:697 ||| JJ
care  ||| S:697 E:702 ||| NN
hospital ||| S:702 E:710 ||| NN
.  ||| S:710 E:712 ||| .
The  ||| S:712 E:716 ||| DT
variables  ||| S:716 E:726 ||| JJ
studied  ||| S:726 E:734 ||| NN
were  ||| S:734 E:739 ||| VBD
AE  ||| S:739 E:742 ||| NNP
and  ||| S:742 E:746 ||| CC
incidents ||| S:746 E:755 ||| NNS
.  ||| S:755 E:757 ||| .
We  ||| S:757 E:760 ||| PRP
used  ||| S:760 E:765 ||| VBD
the  ||| S:765 E:769 ||| DT
AE  ||| S:769 E:772 ||| NNP
screening  ||| S:772 E:782 ||| NN
guide  ||| S:782 E:788 ||| NN
adapted  ||| S:788 E:796 ||| VBD
to  ||| S:796 E:799 ||| TO
the  ||| S:799 E:803 ||| DT
Harvard  ||| S:803 E:811 ||| NNP
study  ||| S:811 E:817 ||| NN
and  ||| S:817 E:821 ||| CC
the  ||| S:821 E:825 ||| DT
Spanish  ||| S:825 E:833 ||| JJ
version  ||| S:833 E:841 ||| NN
of  ||| S:841 E:844 ||| IN
the  ||| S:844 E:848 ||| DT
Modular  ||| S:848 E:856 ||| NNP
Review  ||| S:856 E:863 ||| NNP
Form  ||| S:863 E:868 ||| NNP
( ||| S:868 E:869 ||| -LRB-
MRF2 ||| S:869 E:873 ||| NNP
)  ||| S:873 E:875 ||| -RRB-
for  ||| S:875 E:879 ||| IN
case  ||| S:879 E:884 ||| NN
record  ||| S:884 E:891 ||| NN
review ||| S:891 E:897 ||| NN
.  ||| S:897 E:899 ||| .
Data  ||| S:899 E:904 ||| NNP
analysis  ||| S:904 E:913 ||| NN
consisted  ||| S:913 E:923 ||| VBD
of  ||| S:923 E:926 ||| IN
calculation  ||| S:926 E:938 ||| NN
of  ||| S:938 E:941 ||| IN
the  ||| S:941 E:945 ||| DT
global  ||| S:945 E:952 ||| JJ
predictive  ||| S:952 E:963 ||| JJ
value  ||| S:963 E:969 ||| NN
of  ||| S:969 E:972 ||| IN
the  ||| S:972 E:976 ||| DT
screening  ||| S:976 E:986 ||| NN
guide ||| S:986 E:991 ||| NN
,  ||| S:991 E:993 ||| ,
the  ||| S:993 E:997 ||| DT
item-by-item  ||| S:997 E:1010 ||| JJ
predictive  ||| S:1010 E:1021 ||| JJ
value ||| S:1021 E:1026 ||| NN
,  ||| S:1026 E:1028 ||| ,
and  ||| S:1028 E:1032 ||| CC
the  ||| S:1032 E:1036 ||| DT
percentage  ||| S:1036 E:1047 ||| NN
of  ||| S:1047 E:1050 ||| IN
AE  ||| S:1050 E:1053 ||| NNP
detected  ||| S:1053 E:1062 ||| VBD
by  ||| S:1062 E:1065 ||| IN
each  ||| S:1065 E:1070 ||| DT
alert ||| S:1070 E:1075 ||| NN
.  ||| S:1075 E:1077 ||| .
Of  ||| S:1077 E:1080 ||| IN
the  ||| S:1080 E:1084 ||| DT
19  ||| S:1084 E:1087 ||| CD
criteria  ||| S:1087 E:1096 ||| NNS
in  ||| S:1096 E:1099 ||| IN
the  ||| S:1099 E:1103 ||| DT
screening  ||| S:1103 E:1113 ||| NN
guide ||| S:1113 E:1118 ||| NN
,  ||| S:1118 E:1120 ||| ,
the  ||| S:1120 E:1124 ||| DT
most  ||| S:1124 E:1129 ||| RBS
frequently  ||| S:1129 E:1140 ||| RB
marked  ||| S:1140 E:1147 ||| VBD
criterion  ||| S:1147 E:1157 ||| VBN
in  ||| S:1157 E:1160 ||| IN
both  ||| S:1160 E:1165 ||| PDT
the  ||| S:1165 E:1169 ||| DT
cohort  ||| S:1169 E:1176 ||| NN
and  ||| S:1176 E:1180 ||| CC
prevalence  ||| S:1180 E:1191 ||| JJ
studies  ||| S:1191 E:1199 ||| NNS
was  ||| S:1199 E:1203 ||| VBD
criterion  ||| S:1203 E:1213 ||| JJ
number  ||| S:1213 E:1220 ||| NN
1  ||| S:1220 E:1222 ||| CD
( ||| S:1222 E:1223 ||| -LRB-
prior  ||| S:1223 E:1229 ||| JJ
hospitalization  ||| S:1229 E:1245 ||| NN
during  ||| S:1245 E:1252 ||| IN
the  ||| S:1252 E:1256 ||| DT
last  ||| S:1256 E:1261 ||| JJ
year  ||| S:1261 E:1266 ||| NN
in  ||| S:1266 E:1269 ||| IN
patients  ||| S:1269 E:1278 ||| NNS
less  ||| S:1278 E:1283 ||| RBR
than  ||| S:1283 E:1288 ||| IN
65  ||| S:1288 E:1291 ||| CD
years  ||| S:1291 E:1297 ||| NNS
old  ||| S:1297 E:1301 ||| JJ
or  ||| S:1301 E:1304 ||| CC
prior  ||| S:1304 E:1310 ||| JJ
hospitalization  ||| S:1310 E:1326 ||| NN
in  ||| S:1326 E:1329 ||| IN
the  ||| S:1329 E:1333 ||| DT
last  ||| S:1333 E:1338 ||| JJ
6  ||| S:1338 E:1340 ||| CD
months  ||| S:1340 E:1347 ||| NNS
in  ||| S:1347 E:1350 ||| IN
patients  ||| S:1350 E:1359 ||| NNS
65  ||| S:1359 E:1362 ||| CD
years  ||| S:1362 E:1368 ||| NNS
old  ||| S:1368 E:1372 ||| JJ
or  ||| S:1372 E:1375 ||| CC
older ||| S:1375 E:1380 ||| JJR
) ||| S:1380 E:1381 ||| -RRB-
.  ||| S:1381 E:1383 ||| .
Of  ||| S:1383 E:1386 ||| IN
all  ||| S:1386 E:1390 ||| PDT
the  ||| S:1390 E:1394 ||| DT
AE  ||| S:1394 E:1397 ||| NNP
and  ||| S:1397 E:1401 ||| CC
complications  ||| S:1401 E:1415 ||| NNS
detected ||| S:1415 E:1423 ||| VBD
,  ||| S:1423 E:1425 ||| ,
57.2 ||| S:1425 E:1429 ||| CD
%  ||| S:1429 E:1431 ||| NN
were  ||| S:1431 E:1436 ||| VBD
screened  ||| S:1436 E:1445 ||| VBN
with  ||| S:1445 E:1450 ||| IN
warning  ||| S:1450 E:1458 ||| VBG
criteria  ||| S:1458 E:1467 ||| NNS
17  ||| S:1467 E:1470 ||| CD
and  ||| S:1470 E:1474 ||| CC
19 ||| S:1474 E:1476 ||| CD
,  ||| S:1476 E:1478 ||| ,
corresponding  ||| S:1478 E:1492 ||| JJ
to  ||| S:1492 E:1495 ||| TO
another  ||| S:1495 E:1503 ||| DT
AE  ||| S:1503 E:1506 ||| NNP
and  ||| S:1506 E:1510 ||| CC
any  ||| S:1510 E:1514 ||| DT
kind  ||| S:1514 E:1519 ||| NN
of  ||| S:1519 E:1522 ||| IN
nosocomial  ||| S:1522 E:1533 ||| JJ
infection ||| S:1533 E:1542 ||| NN
.  ||| S:1542 E:1544 ||| .
Overall ||| S:1544 E:1551 ||| RB
,  ||| S:1551 E:1553 ||| ,
the  ||| S:1553 E:1557 ||| DT
screening  ||| S:1557 E:1567 ||| NN
guide  ||| S:1567 E:1573 ||| NN
had  ||| S:1573 E:1577 ||| VBD
positive  ||| S:1577 E:1586 ||| JJ
predictive  ||| S:1586 E:1597 ||| JJ
value  ||| S:1597 E:1603 ||| NN
( ||| S:1603 E:1604 ||| -LRB-
PPV ||| S:1604 E:1607 ||| NNP
)  ||| S:1607 E:1609 ||| -RRB-
of  ||| S:1609 E:1612 ||| IN
24.3 ||| S:1612 E:1616 ||| CD
%  ||| S:1616 E:1618 ||| NN
in  ||| S:1618 E:1621 ||| IN
the  ||| S:1621 E:1625 ||| DT
cohort  ||| S:1625 E:1632 ||| JJ
study ||| S:1632 E:1637 ||| NN
,  ||| S:1637 E:1639 ||| ,
and  ||| S:1639 E:1643 ||| CC
a  ||| S:1643 E:1645 ||| DT
PPV  ||| S:1645 E:1649 ||| NNP
of  ||| S:1649 E:1652 ||| IN
37.4 ||| S:1652 E:1656 ||| CD
%  ||| S:1656 E:1658 ||| NN
in  ||| S:1658 E:1661 ||| IN
the  ||| S:1661 E:1665 ||| DT
cross-sectional  ||| S:1665 E:1681 ||| JJ
study  ||| S:1681 E:1687 ||| NN
when  ||| S:1687 E:1692 ||| WRB
all  ||| S:1692 E:1696 ||| DT
types  ||| S:1696 E:1702 ||| NNS
of  ||| S:1702 E:1705 ||| IN
AE  ||| S:1705 E:1708 ||| NNP
were  ||| S:1708 E:1713 ||| VBD
included  ||| S:1713 E:1722 ||| VBN
( ||| S:1722 E:1723 ||| -LRB-
i.e.  ||| S:1723 E:1728 ||| FW
AE  ||| S:1728 E:1731 ||| FW
associated  ||| S:1731 E:1742 ||| VBN
with  ||| S:1742 E:1747 ||| IN
healthcare ||| S:1747 E:1757 ||| NN
,  ||| S:1757 E:1759 ||| ,
disease  ||| S:1759 E:1767 ||| NN
and  ||| S:1767 E:1771 ||| CC
incidents ||| S:1771 E:1780 ||| NNS
) ||| S:1780 E:1781 ||| -RRB-
.  ||| S:1781 E:1783 ||| .
Screening  ||| S:1783 E:1793 ||| VBG
criteria  ||| S:1793 E:1802 ||| NNS
10  ||| S:1802 E:1805 ||| CD
( ||| S:1805 E:1806 ||| -LRB-
new  ||| S:1806 E:1810 ||| JJ
neurological  ||| S:1810 E:1823 ||| JJ
deficit  ||| S:1823 E:1831 ||| NN
at  ||| S:1831 E:1834 ||| IN
hospital  ||| S:1834 E:1843 ||| NN
discharge ||| S:1843 E:1852 ||| NN
) ||| S:1852 E:1853 ||| -RRB-
,  ||| S:1853 E:1855 ||| ,
11  ||| S:1855 E:1858 ||| CD
( ||| S:1858 E:1859 ||| -LRB-
acute  ||| S:1859 E:1865 ||| FW
myocardial  ||| S:1865 E:1876 ||| FW
infarction ||| S:1876 E:1886 ||| FW
,  ||| S:1886 E:1888 ||| ,
stroke  ||| S:1888 E:1895 ||| NN
or  ||| S:1895 E:1898 ||| CC
pulmonary  ||| S:1898 E:1908 ||| JJ
thromboembolism  ||| S:1908 E:1924 ||| NN
during  ||| S:1924 E:1931 ||| IN
or  ||| S:1931 E:1934 ||| CC
after  ||| S:1934 E:1940 ||| IN
an  ||| S:1940 E:1943 ||| DT
invasive  ||| S:1943 E:1952 ||| JJ
procedure ||| S:1952 E:1961 ||| NN
) ||| S:1961 E:1962 ||| -RRB-
,  ||| S:1962 E:1964 ||| ,
12  ||| S:1964 E:1967 ||| CD
( ||| S:1967 E:1968 ||| -LRB-
cardiorespiratory  ||| S:1968 E:1986 ||| JJ
arrest  ||| S:1986 E:1993 ||| NN
or  ||| S:1993 E:1996 ||| CC
low  ||| S:1996 E:2000 ||| JJ
Apgar  ||| S:2000 E:2006 ||| JJ
score ||| S:2006 E:2011 ||| NN
)  ||| S:2011 E:2013 ||| -RRB-
and  ||| S:2013 E:2017 ||| CC
13  ||| S:2017 E:2020 ||| CD
( ||| S:2020 E:2021 ||| -LRB-
injury  ||| S:2021 E:2028 ||| NN
or  ||| S:2028 E:2031 ||| CC
complication  ||| S:2031 E:2044 ||| NN
related  ||| S:2044 E:2052 ||| VBN
to  ||| S:2052 E:2055 ||| TO
abortion ||| S:2055 E:2063 ||| NN
,  ||| S:2063 E:2065 ||| ,
amniocentesis ||| S:2065 E:2078 ||| NN
,  ||| S:2078 E:2080 ||| ,
delivery  ||| S:2080 E:2089 ||| NN
or  ||| S:2089 E:2092 ||| CC
pre-delivery ||| S:2092 E:2104 ||| NNP
)  ||| S:2104 E:2106 ||| -RRB-
were  ||| S:2106 E:2111 ||| VBD
not  ||| S:2111 E:2115 ||| RB
marked  ||| S:2115 E:2122 ||| VBN
in  ||| S:2122 E:2125 ||| IN
any  ||| S:2125 E:2129 ||| DT
type  ||| S:2129 E:2134 ||| NN
of  ||| S:2134 E:2137 ||| IN
study ||| S:2137 E:2142 ||| NN
.  ||| S:2142 E:2144 ||| .
The  ||| S:2144 E:2148 ||| DT
utility  ||| S:2148 E:2156 ||| NN
of  ||| S:2156 E:2159 ||| IN
the  ||| S:2159 E:2163 ||| DT
screening  ||| S:2163 E:2173 ||| NN
guide  ||| S:2173 E:2179 ||| NN
is  ||| S:2179 E:2182 ||| VBZ
low  ||| S:2182 E:2186 ||| JJ
when  ||| S:2186 E:2191 ||| WRB
used  ||| S:2191 E:2196 ||| VBN
in  ||| S:2196 E:2199 ||| IN
a  ||| S:2199 E:2201 ||| DT
long-stay  ||| S:2201 E:2211 ||| JJ
chronic  ||| S:2211 E:2219 ||| JJ
care  ||| S:2219 E:2224 ||| NN
hospital ||| S:2224 E:2232 ||| NN
.  ||| S:2232 E:2234 ||| .
A  ||| S:2234 E:2236 ||| DT
new  ||| S:2236 E:2240 ||| JJ
screening  ||| S:2240 E:2250 ||| NN
guide  ||| S:2250 E:2256 ||| NN
is  ||| S:2256 E:2259 ||| VBZ
required  ||| S:2259 E:2268 ||| VBN
that  ||| S:2268 E:2273 ||| IN
excludes  ||| S:2273 E:2282 ||| JJ
inefficient  ||| S:2282 E:2294 ||| JJ
criteria  ||| S:2294 E:2303 ||| NNS
and  ||| S:2303 E:2307 ||| CC
includes  ||| S:2307 E:2316 ||| VBZ
new ||| S:2316 E:2319 ||| JJ
,  ||| S:2319 E:2321 ||| ,
more  ||| S:2321 E:2326 ||| RBR
specific  ||| S:2326 E:2335 ||| JJ
criteria  ||| S:2335 E:2344 ||| NNS
that  ||| S:2344 E:2349 ||| WDT
take  ||| S:2349 E:2354 ||| VBP
into  ||| S:2354 E:2359 ||| IN
account  ||| S:2359 E:2367 ||| NN
the  ||| S:2367 E:2371 ||| DT
characteristics  ||| S:2371 E:2387 ||| NN
of  ||| S:2387 E:2390 ||| IN
patients  ||| S:2390 E:2399 ||| NNS
with  ||| S:2399 E:2404 ||| IN
multimorbidity ||| S:2404 E:2418 ||| NN
.  ||| S:2418 E:2420 ||| .
